Victory Capital Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-453
| Closed | -$8.84K | – | 2528 |
|
|
2024
Q1 | $8.84K | Sell |
453
-49
| -10% | -$956 | ﹤0.01% | 2465 |
|
|
2023
Q4 | $10.4K | Buy |
502
+97
| +24% | +$2.01K | ﹤0.01% | 2528 |
|
|
2023
Q3 | $12.9K | Buy |
405
+31
| +8% | +$985 | ﹤0.01% | 2471 |
|
|
2023
Q2 | $12.6K | Sell |
374
-9
| -2% | -$303 | ﹤0.01% | 2476 |
|
|
2023
Q1 | $16K | Sell |
383
-16
| -4% | -$667 | ﹤0.01% | 2523 |
|
|
2022
Q4 | $13.5K | Hold |
399
| – | – | ﹤0.01% | 2532 |
|
|
2022
Q3 | $20K | Sell |
399
-170
| -30% | -$8.52K | ﹤0.01% | 2628 |
|
|
2022
Q2 | $22K | Buy |
569
+35
| +7% | +$1.35K | ﹤0.01% | 2608 |
|
|
2022
Q1 | $12K | Buy |
534
+127
| +31% | +$2.85K | ﹤0.01% | 2671 |
|
|
2021
Q4 | $40K | Sell |
407
-7
| -2% | -$688 | ﹤0.01% | 2656 |
|
|
2021
Q3 | $52K | Sell |
414
-8
| -2% | -$1.01K | ﹤0.01% | 2684 |
|
|
2021
Q2 | $53K | Sell |
422
-17
| -4% | -$2.14K | ﹤0.01% | 2661 |
|
|
2021
Q1 | $60K | Sell |
439
-13
| -3% | -$1.78K | ﹤0.01% | 2653 |
|
|
2020
Q4 | $41K | Sell |
452
-19
| -4% | -$1.72K | ﹤0.01% | 2470 |
|
|
2020
Q3 | $35K | Buy |
+471
| New | +$35K | ﹤0.01% | 2401 |
|
|
2020
Q2 | – | Sell |
-369
| Closed | -$26K | – | 3132 |
|
|
2020
Q1 | $26K | Buy |
+369
| New | +$26K | ﹤0.01% | 3013 |
|
|
2019
Q4 | – | Sell |
-242
| Closed | -$13K | – | 3152 |
|
|
2019
Q3 | $13K | Buy |
+242
| New | +$13K | ﹤0.01% | 3178 |
|